Source:http://linkedlifedata.com/resource/pubmed/id/10209485
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1999-4-26
|
pubmed:abstractText |
Lymphoepithelioma-like carcinoma (LELC) of the lung is a recently recognized primary non-small cell lung carcinoma with distinct clinicopathological features and an aetiological association with Epstein-Barr virus (EBV) infection. The tumour consists of clusters and sheets of poorly or undifferentiated tumour cells in close association with numerous mononuclear inflammatory cells, including a rich component of tumour-associated macrophages (TAMs). To investigate the molecular mechanism leading to the TAM-rich stroma, the expression of a monocyte-specific chemotactic and activating factor, monocyte chemoattractant protein-1 (MCP-1), was studied by reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH), and the presence of TAMs was demonstrated by immunohistochemistry in nine LELCs. The results were compared with those found in 17 conventional non-small cell lung carcinomas. RT-PCR showed specific MCP-1 amplification in both LELCs and non-LELCs, but ISH demonstrated a unique and extensive expression of MCP-1 transcripts by the tumour cells of LELCs only, while TAMs, stromal fibroblasts, and endothelial cells formed the major source of MCP-1 in non-LELCs. TAMs in LELCs were more abundant and showed a close topographical relationship with the MCP-1-expressing tumour cells. The results indicate that tumour cell expression of MCP-1 in LELCs is an important mechanism contributing to their distinctive morphological features. This is the first study that demonstrates the in vivo upregulation of a monocyte-specific chemokine by EBV-related carcinomas, illustrating an interesting aspect of tumour biology in EBV-related neoplasms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-3417
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
186
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
372-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10209485-Adult,
pubmed-meshheading:10209485-Aged,
pubmed-meshheading:10209485-Carcinoma, Squamous Cell,
pubmed-meshheading:10209485-Chemokine CCL2,
pubmed-meshheading:10209485-Epstein-Barr Virus Infections,
pubmed-meshheading:10209485-Female,
pubmed-meshheading:10209485-Humans,
pubmed-meshheading:10209485-Immunoenzyme Techniques,
pubmed-meshheading:10209485-In Situ Hybridization,
pubmed-meshheading:10209485-Lung Neoplasms,
pubmed-meshheading:10209485-Macrophages,
pubmed-meshheading:10209485-Male,
pubmed-meshheading:10209485-Middle Aged,
pubmed-meshheading:10209485-Neoplasm Proteins,
pubmed-meshheading:10209485-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
1998
|
pubmed:articleTitle |
Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung.
|
pubmed:affiliation |
Department of Pathology, University of Hong Kong, Queen Mary Hospital, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|